Evotec Analyst Price Targets - Benzinga

Evotec SE

EVONASDAQ

Trade with Public

Trade with Public

$1.81

-0.01-0.55%

At close: Sep 9, 5:00 PM EST

$1.81

N/A

After Hours: 4:27 PM EST

Overview News Earnings ForecastPrice TargetsFinancials Sentiment Ownership Compare Stock Report

Evotec Analyst Price Targets

Wall Street analyst price targets and consensus rating for Evotec (EVO).

Price Target Range — 5 Quarters

Analyst Consensus — 2 Analysts

1Buy

1Hold

Consensus RatingBuy# Analysts2Avg. Consensus PT$5Upside to Avg. PT+172.4%

Rating Trend — Last 9 Months

Recent Analyst Actions

See all ratings →

Date	Firm	Analyst	Action	Rating Change	Price Target
Jul 15, 2026	HC Wainwright & Co.	Swayampakula Ramakanth	PT Cut	Buy	$7→$4
Aug 14, 2025	HC Wainwright & Co.	Douglas Tsao	PT Cut	Buy	$8→$7
Nov 7, 2024	HC Wainwright & Co.	Douglas Tsao	Maintained	Buy	$8
Oct 7, 2024	Jefferies	Benjamin Jackson	Downgrade	Buy→Hold	$9→$4
Aug 15, 2024	HC Wainwright & Co.	Douglas Tsao	PT Cut	Buy	$11→$8
May 23, 2024	HC Wainwright & Co.	Douglas Tsao	Maintained	Buy	$11
Apr 25, 2024	HC Wainwright & Co.	Douglas Tsao	PT Cut	Buy	$14→$11

More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
HC Wainwright & Co. Maintains Buy on Evotec, Lowers Price Target to $4

HC Wainwright & Co. analyst Swayampakula Ramakanth maintains Evotec (NASDAQ:EVO) with a Buy and lowers the price target from $7 to $4.

Benzinga Newsdesk

PRO
HC Wainwright & Co. Maintains Buy on Evotec, Lowers Price Target to $7

HC Wainwright & Co. analyst Douglas Tsao maintains Evotec (NASDAQ:EVO) with a Buy and lowers the price target from $8 to $7.

Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Buy on Evotec, Maintains $8 Price Target

HC Wainwright & Co. analyst Douglas Tsao reiterates Evotec (NASDAQ:EVO) with a Buy and maintains $8 price target.

Benzinga Newsdesk

PRO
Jefferies Downgrades Evotec to Hold, Lowers Price Target to $3.8

Jefferies analyst Benjamin Jackson downgrades Evotec (NASDAQ:EVO) from Buy to Hold and lowers the price target from $8.7 to $3.8.

Benzinga Newsdesk

PRO
HC Wainwright & Co. Maintains Buy on Evotec, Lowers Price Target to $8

HC Wainwright & Co. analyst Douglas Tsao maintains Evotec (NASDAQ:EVO) with a Buy and lowers the price target from $11 to $8.

Benzinga Newsdesk

Evotec Rises 12% on $75M Milestone Payment From BMY

Evotec (NASDAQ: EVO) achieved substantial progress in its strategic partnership with Bristol Myers Squibb (NYSE: BMY) relating to building a molecular glue-based pipeline.

Zacks